Corbus Pharmaceuticals Holdings (CRBP) Non-Current Deffered Revenue (2015 - 2018)

Corbus Pharmaceuticals Holdings' Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $422337.0 for Q4 2018.

• In Q4 2018, Non-Current Deffered Revenue fell 57.32% year-over-year to $422337.0; the TTM figure through Dec 2018 stood at $422337.0 (down 57.32% YoY), while the FY2018 annual figure was $422337.0, down 57.32% from the prior year.
• Non-Current Deffered Revenue was $422337.0 for Q4 2018 at Corbus Pharmaceuticals Holdings, up from $392846.0 in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $1.4 million in Q2 2018 to a low of $58206.0 in Q2 2017.
• Historically, Non-Current Deffered Revenue has averaged $480735.8 across 4 years, with a median of $338470.0 in 2015.
• The sharpest annual moves came in 2016 and 2018: Non-Current Deffered Revenue slumped 74.75% in 2016, then surged 2224.34% in 2018.
• A 4-year view of Non-Current Deffered Revenue shows it stood at $260260.0 in 2015, then plunged by 74.75% to $65724.0 in 2016, then soared by 1405.61% to $989550.0 in 2017, then plunged by 57.32% to $422337.0 in 2018.
• The last three Non-Current Deffered Revenue figures came in at $422337.0 (Q4 2018), $392846.0 (Q3 2018), and $1.4 million (Q2 2018), per Business Quant data.